- Home
- IPGP vs JANX Comparison
IPGP vs JANX Comparison
Compare IPGP & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPGP
- JANX
- Stock Information
- Founded
- IPGP 1990
- JANX 2017
- Country
- IPGP United States
- JANX United States
- Employees
- IPGP N/A
- JANX N/A
- Industry
- IPGP Semiconductors
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- IPGP Technology
- JANX Health Care
- Exchange
- IPGP Nasdaq
- JANX Nasdaq
- Market Cap
- IPGP 3.3B
- JANX 3.6B
- IPO Year
- IPGP 2006
- JANX 2021
- Fundamental
- Price
- IPGP $73.84
- JANX $56.83
- Analyst Decision
- IPGP Hold
- JANX Strong Buy
- Analyst Count
- IPGP 6
- JANX 11
- Target Price
- IPGP $89.33
- JANX $83.09
- AVG Volume (30 Days)
- IPGP 313.6K
- JANX 1.7M
- Earning Date
- IPGP 02-11-2025
- JANX 11-06-2024
- Dividend Yield
- IPGP N/A
- JANX N/A
- EPS Growth
- IPGP N/A
- JANX N/A
- EPS
- IPGP N/A
- JANX N/A
- Revenue
- IPGP $1,041,690,000.00
- JANX $13,049,000.00
- Revenue This Year
- IPGP N/A
- JANX $40.27
- Revenue Next Year
- IPGP $7.11
- JANX N/A
- P/E Ratio
- IPGP N/A
- JANX N/A
- Revenue Growth
- IPGP N/A
- JANX 54.12
- 52 Week Low
- IPGP $61.86
- JANX $7.79
- 52 Week High
- IPGP $111.11
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- IPGP 41.76
- JANX 50.66
- Support Level
- IPGP $72.81
- JANX $54.20
- Resistance Level
- IPGP $79.62
- JANX $66.34
- Average True Range (ATR)
- IPGP 2.90
- JANX 5.47
- MACD
- IPGP -0.45
- JANX -0.57
- Stochastic Oscillator
- IPGP 10.98
- JANX 15.02
About IPGP IPG Photonics Corporation
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from China and also has its presence in North America, Japan, Germany, and other markets.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.